Trial Profile
Advanced Cardiac Safety Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Apr 2009
Price :
$35
*
At a glance
- Drugs Dextromethorphan/quinidine (Primary) ; Moxifloxacin
- Indications Agitation; Bacterial infections; Diabetic neuropathies; Emotional lability; Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- Acronyms ACSS
- Sponsors Avanir Pharmaceuticals
- 17 Apr 2009 New trial record.
- 02 Apr 2009 Results reported in an Avanir media release.